ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-11Q13104
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global ICAD Intracranial Atherosclerotic Disease Pathology Market Research Report 2023
BUY CHAPTERS

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2026

Code: QYRE-Auto-11Q13104
Report
2026-02-11
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH

ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 222 million in 2025 and is anticipated to reach US$ 397 million by 2032, at a CAGR of 8.8% from 2026 to 2032.

ICAD (Intracranial Atherosclerotic Disease) Pathology Market

ICAD (Intracranial Atherosclerotic Disease) Pathology Market

ICAD (Intracranial Atherosclerotic Disease) pathology is the scientific study of atherosclerotic plaque formation, progression, and the mechanisms by which intracranial arterial disease leads to ischemic brain events. It spans vessel wall changes, inflammation, plaque instability, and thrombosis, linking histopathology to imaging signatures (e.g., high-resolution vessel-wall MRI, CTA, DSA). ICAD pathology underpins clinical diagnosis, endovascular therapeutic design, pharmacologic interventions, and secondary prevention strategies. With the rise of molecular pathology, imaging-omics, and digital pathology, the field is shifting from descriptive characterization toward quantifiable risk stratification and personalized treatment guidance, serving as the integrative hub between basic science, clinical imaging, and medical-device innovation.The average gross profit margin for this product is 70%.
Intracranial atherosclerotic disease is increasingly prioritized in national public-health agendas, prompting systematic upgrades across screening-to-treatment pathways. Industry opportunities arise along three lines: improved diagnostic power through combined imaging-pathology workflows enabling early detection and lesion phenotyping; rising clinical acceptance of endovascular and minimally invasive therapies creating steady demand for dedicated stents, balloons and integrated procedural solutions; and healthcare consolidation that drives hospitals and networks to invest in standardized, traceable ICAD care pathways. These drivers are highlighted in companies’ public disclosures and capital-market materials, creating growth windows for firms that combine technology, brand, and service models.
Despite the attractive outlook, ICAD pathology and related clinical solutions face regulatory, evidentiary, and implementation challenges. Novel diagnostic and interventional products must achieve guideline-level acceptance supported by rigorous clinical trials, which are complex and time-consuming. Lesion heterogeneity across regions and populations complicates universal product applicability and commercial roll-out. Moreover, reimbursement variability and uneven base-level imaging/pathology capabilities limit near-term penetration of high-end imaging and precision-pathology services. Industry players must balance technical robustness with clinical practicality.
Clinical demand is shifting from pure acute revascularization to chronic disease management and risk visualization. Large neurovascular centers favor integrated imaging–pathology–follow-up datasets to support individualized secondary prevention choices. Hospitals and regional networks increasingly prefer standardized imaging reports, automated analytics, and peri-procedural imaging/pathology correlation services. Patient safety, traceability, and quality control are key drivers, favoring imaging+pathology platforms with closed-loop data capabilities and seamless HIS integration.
The upstream ecosystem for ICAD encompasses hardware (high-resolution MRI, CTA/DSA scanners, interventional device materials) and software/reagents (post-processing algorithms, vessel-wall sequences, histology and molecular assay reagents). The capabilities of high-end imaging and precision interventional suppliers set the ceiling for lesion detection and procedural feasibility. Equally critical are the maturity of imaging-sequence optimization, AI-driven image analysis, and digital pathology workflows that convert imaging features into actionable clinical information. Some critical components and advanced imaging modules still depend on global supply chains; public disclosures indicate that strengthening local supply capabilities and strategic partnerships will be vital to secure supply continuity and cost control.
This report delivers a comprehensive overview of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology. The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global ICAD (Intracranial Atherosclerotic Disease) Pathology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report

Report Metric Details
Report Name ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Accounted market size in 2025 US$ 222 million
Forecasted market size in 2032 US$ 397 million
CAGR 8.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Stent
  • PTA Balloon
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for ICAD (Intracranial Atherosclerotic Disease) Pathology companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is ICAD (Intracranial Atherosclerotic Disease) Pathology Market growing?

Ans: The ICAD (Intracranial Atherosclerotic Disease) Pathology Market witnessing a CAGR of 8.8% during the forecast period 2026-2032.

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2032?

Ans: The ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2032 will be US$ 397 million.

Who are the main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Applications covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Types covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Stent, PTA Balloon

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Perspective (2021–2032)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Trends by Region
2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Region (2021–2026)
2.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region (2027–2032)
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
2.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
2.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
2.3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
2.3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Revenue
3.1.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Revenue (2021–2026)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players (2021–2026)
3.2 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio
3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2025
3.5 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Head Offices and Areas Served
3.6 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Products and Applications
3.7 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Type
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Type (2021–2026)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (2027–2032)
5 ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Application
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Application (2021–2026)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021–2032)
6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2021–2026)
6.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021–2032)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2021–2026)
7.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021–2032)
8.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (2021–2026)
8.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021–2032)
9.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2021–2026)
9.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021–2032)
10.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2021–2026)
10.4 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
11.1.4 Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
11.1.5 Stryker Recent Development
11.2 Balt
11.2.1 Balt Company Details
11.2.2 Balt Business Overview
11.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
11.2.4 Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
11.2.5 Balt Recent Development
11.3 TERUMO
11.3.1 TERUMO Company Details
11.3.2 TERUMO Business Overview
11.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
11.3.4 TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
11.3.5 TERUMO Recent Development
11.4 MicroPort
11.4.1 MicroPort Company Details
11.4.2 MicroPort Business Overview
11.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
11.4.4 MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
11.4.5 MicroPort Recent Development
11.5 Acandis
11.5.1 Acandis Company Details
11.5.2 Acandis Business Overview
11.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
11.5.4 Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
11.5.5 Acandis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH
List of Tables
 Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Stent
 Table 3. Key Players of PTA Balloon
 Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million), 2021–2026
 Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Region (2021–2026)
 Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Region (2027–2032)
 Table 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
 Table 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
 Table 12. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
 Table 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
 Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (US$ Million), 2021–2026
 Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Players (2021–2026)
 Table 16. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Tier (Tier 1, Tier 2, and Tier 3), based on ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2025
 Table 17. Ranking of Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Headquarters and Area Served
 Table 20. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Products and Applications
 Table 21. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (US$ Million), 2021–2026
 Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021–2026)
 Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2027–2032)
 Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (US$ Million), 2021–2026
 Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021–2026)
 Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2027–2032)
 Table 31. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2021–2026
 Table 33. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country (US$ Million), 2027–2032
 Table 46. Stryker Company Details
 Table 47. Stryker Business Overview
 Table 48. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 49. Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (US$ Million), 2021–2026
 Table 50. Stryker Recent Development
 Table 51. Balt Company Details
 Table 52. Balt Business Overview
 Table 53. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 54. Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (US$ Million), 2021–2026
 Table 55. Balt Recent Development
 Table 56. TERUMO Company Details
 Table 57. TERUMO Business Overview
 Table 58. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 59. TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (US$ Million), 2021–2026
 Table 60. TERUMO Recent Development
 Table 61. MicroPort Company Details
 Table 62. MicroPort Business Overview
 Table 63. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 64. MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (US$ Million), 2021–2026
 Table 65. MicroPort Recent Development
 Table 66. Acandis Company Details
 Table 67. Acandis Business Overview
 Table 68. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
 Table 69. Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (US$ Million), 2021–2026
 Table 70. Acandis Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Picture
 Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type: 2025 vs 2032
 Figure 4. Stent Features
 Figure 5. PTA Balloon Features
 Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Other Case Studies
 Figure 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
 Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Region: 2025 vs 2032
 Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Players in 2025
 Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2025
 Figure 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2021–2032)
 Figure 20. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2021–2032)
 Figure 24. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Region (2021–2032)
 Figure 32. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2021–2032)
 Figure 40. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Country (2021–2032)
 Figure 44. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Stryker Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
 Figure 48. Balt Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
 Figure 49. TERUMO Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
 Figure 50. MicroPort Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
 Figure 51. Acandis Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2021–2026)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

ICAD Intracranial Atherosclerotic Disease Pathology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intracranial Atherosclerotic Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Aneurysm Treatment Market Insights Forecast to 2030
Intracranial Stent System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Stents Market Research Report 2025
Global Balloon expanded Intracranial Stents Market Research Report 2024
Global Atherosclerosis Therapeutics Market Insights Forecast to 2030
Global Cerebrovascular Disease Market Research Report 2024
Global Self expandable Intracranial Stents Market Research Report 2024
Global Ischemic Neurointerventional Device Market Research Report 2025
Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Research Report 2024
Global AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market Research Report 2024
Global Cerebral Infarction Therapy Market Insights Forecast to 2030
Ischemic Cerebrovascular Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coronary Artery Disease Therapeutics Market Research Report 2024
Brain Ischemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cerebral Aneurysm Covered Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intrasaccular Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peripheral Artery Disease Treatment Devices Market Research Report 2024
Global Coronary Artery Imaging Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions